134 related articles for article (PubMed ID: 12745661)
21. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
Buonamici S; Ottaviani E; Testoni N; Montefusco V; Visani G; Bonifazi F; Amabile M; Terragna C; Ruggeri D; Piccaluga PP; Isidori A; Malagola M; Baccarani M; Tura S; Martinelli G
Blood; 2002 Jan; 99(2):443-9. PubMed ID: 11781223
[TBL] [Abstract][Full Text] [Related]
22. Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo.
Merchant SH; Haines S; Hall B; Hozier J; Viswanatha DS
J Mol Diagn; 2004 Aug; 6(3):271-4. PubMed ID: 15269306
[TBL] [Abstract][Full Text] [Related]
23. Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.
Zhang W; Wang H; Zhang P; Li H; Ma X; Liu H
Braz J Med Biol Res; 2021; 54(12):e11605. PubMed ID: 34730684
[TBL] [Abstract][Full Text] [Related]
24. [Detection of CBFbeta/MYH11 fusion transcripts and study of the mechanism of leukemogenesis of CBFbeta/SMHHC fusion protein].
Xu SC; Yang L; Zhou X; Feng M; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):332-5. PubMed ID: 16185474
[TBL] [Abstract][Full Text] [Related]
25. Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
Martinelli G; Rondoni M; Buonamici S; Ottaviani E; Piccaluga PP; Malagola M; Baccarani M
Haematologica; 2004 Apr; 89(4):495-7. PubMed ID: 15075086
[TBL] [Abstract][Full Text] [Related]
26. Banding and molecular cytogenetic studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia FAB M4-Eo.
Macedo Silva ML; Raimondi SC; Abdelhay E; Gross M; Mkrtchyan H; de Figueiredo AF; Ribeiro RC; de Jesus Marques-Salles T; Sobral ES; Gerardin Land MP; Liehr T
Cancer Genet Cytogenet; 2008 Apr; 182(1):56-60. PubMed ID: 18328953
[TBL] [Abstract][Full Text] [Related]
27. [Additional chromosomal abnormality of inv(16)(p13q22) to del(7)(q32) in a patient with acute myelomonocytic leukemia].
Ida T; Hashimoto S; Yano T; Sato N; Koike T
Rinsho Ketsueki; 2012 Mar; 53(3):347-51. PubMed ID: 22499053
[TBL] [Abstract][Full Text] [Related]
28. Typical CBFbeta/MYH11 fusion due to insertion of the 3'-MYH11 gene into 16q22 in acute monocytic leukemia with normal chromosomes 16 and trisomies 8 and 22.
Aventín A; La Starza R; Nomdedéu J; Brunet S; Sierra J; Mecucci C
Cancer Genet Cytogenet; 2000 Dec; 123(2):137-9. PubMed ID: 11150605
[TBL] [Abstract][Full Text] [Related]
29. Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Laczika K; Mitterbauer G; Mitterbauer M; Knöbl P; Schwarzinger I; Greinix HT; Rabitsch W; Fonatsch C; Mannhalter C; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(5):923-31. PubMed ID: 11697647
[TBL] [Abstract][Full Text] [Related]
30. CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16.
Pirc-Danoewinata H; Dauwerse HG; König M; Chudoba I; Mitterbauer M; Jäger U; Breuning MH; Haas OA
Genes Chromosomes Cancer; 2000 Oct; 29(2):186-91. PubMed ID: 10959099
[TBL] [Abstract][Full Text] [Related]
31. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
[TBL] [Abstract][Full Text] [Related]
32. Long-term disease-free acute myeloblastic leukemia with inv(16) is associated with PCR undetectable CBFbeta/MYH11 transcript.
Martinelli G; Ottaviani E; Testoni N; Montefusco V; Pastano R; Tura S
Haematologica; 2000 May; 85(5):552-5. PubMed ID: 10800179
[No Abstract] [Full Text] [Related]
33. Myeloid sarcoma of the small bowel associated with a CBFbeta/MYH11 fusion and inv(16)(p13q22): a case report.
McKenna M; Arnold C; Catherwood MA; Humphreys MW; Cuthbert RJ; Bueso-Ramos C; McManus DT
J Clin Pathol; 2009 Aug; 62(8):757-9. PubMed ID: 19638550
[TBL] [Abstract][Full Text] [Related]
34. Childhood acute myeloid leukemia with CBFbeta-MYH11 rearrangement: study of incidence, morphology, cytogenetics, and clinical outcomes of Chinese in Hong Kong.
Chan NP; Wong WS; Ng MH; Tsang KS; Lau TT; Leung Y; Chik KW; Shing MM; Li CK
Am J Hematol; 2004 Jul; 76(3):300-3. PubMed ID: 15224374
[TBL] [Abstract][Full Text] [Related]
35. Clinical aspects of expression of inversion 16 chromosomal fusion transcript CBFB/MYH11 in acute myelogenous leukemia subtype M1 with abnormal bone marrow eosinophilia.
Monahan BP; Rector JT; Liu PP; Cotelingam JD; Dahut W
Leukemia; 1996 Oct; 10(10):1653-4. PubMed ID: 8847901
[TBL] [Abstract][Full Text] [Related]
36. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.
Martinez-Climent JA; Comes AM; Vizcarra E; Reshmi S; Benet I; Marugan I; Tormo M; Terol MJ; Solano C; Arbona C; Prosper F; Barragan E; Bolufer P; Rowley JD; García-Conde J
Cancer Genet Cytogenet; 1999 Apr; 110(2):111-4. PubMed ID: 10214358
[TBL] [Abstract][Full Text] [Related]
37. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
[TBL] [Abstract][Full Text] [Related]
38. Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo.
Hernández JM; González MB; Granada I; Gutiérrez N; Chillón C; Ramos F; Ribera JM; González M; Feliu E; San Miguel J
Haematologica; 2000 May; 85(5):481-5. PubMed ID: 10800163
[TBL] [Abstract][Full Text] [Related]
39. Detection and quantitation of the CBFbeta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML.
Evans PA; Short MA; Jack AS; Norfolk DR; Child JA; Shiach CR; Davies F; Tobal K; Liu Yin JA; Morgan GJ
Leukemia; 1997 Mar; 11(3):364-9. PubMed ID: 9067575
[TBL] [Abstract][Full Text] [Related]
40. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]